Proceedings: Treatment of nonfunctioning chromophobe adenomas of the pituitary.
D000238:Adenoma, Chromophobe / Q000175:diagnosis / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D001706:Biopsy; D001766:Blindness / Q000209:etiology; D001925:Brain Damage, Chronic / Q000209:etiology; D002559:Cerebrospinal Fluid Rhinorrhea / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D020209:Cranial Nerve Injuries; D005132:Eye Manifestations; D005260:Female; D005500:Follow-Up Studies; D006423:Hemianopsia / Q000209:etiology; D006801:Humans; D007016:Hypophysectomy; D007018:Hypopituitarism / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms; D009364:Neoplasm Recurrence, Local; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D011183:Postoperative Complications; D012658:Sella Turcica; D013530:Surgical Wound Infection; D014786:Vision Disorders / Q000209:etiology; D014794:Visual Fields